INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 44h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago

Results

75,408 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
12
AG
Albo GiuseppinaDirector, Chief Executive Officer
HGHamilton Insurance Group, Ltd.
Gift
G—
100.4K sh
Aug 13, 2026Aug 17, 2026
Page 610 of 1886
← PrevNext →
traded Aug 13, 2026
+4d
SEC Form 4

Evidence

12
WM
Weidner MarissaChief Corp. Resp. Officer
WBSWEBSTER FINANCIAL CORP
Tax withholding
F$124K
1,570 sh
Aug 13, 2026Aug 17, 2026
traded Aug 13, 2026
+4dSEC Form 4

Evidence

11
LY
Landman YoavDirector, CHIEF TECHNOLOGY OFFICER
FROGJFrog Ltd
Open-market sale · 10b5-1 plan
SELL$98K
1,100 sh
Aug 13, 2026Aug 17, 2026
traded Aug 13, 2026
+4dSEC Form 4

Evidence

11
OO
Offer OrChief Executive Officer
SMWBSIMILARWEB LTD.
Option exercise
M$695K
228.5K sh
Aug 13, 2026Aug 17, 2026
traded Aug 13, 2026
+4dSEC Form 4

Evidence

11
LY
Landman YoavDirector, CHIEF TECHNOLOGY OFFICER
FROGJFrog Ltd
Open-market sale · 10b5-1 plan
SELL$165K
1,900 sh
Aug 13, 2026Aug 17, 2026
traded Aug 13, 2026
+4dSEC Form 4

Evidence

11
BO
Blachier OlivierPresident, Materials Solutions
ENTGENTEGRIS INC
Option exercise · 10b5-1 plan
M—
2,000 sh
Aug 14, 2026Aug 17, 2026
traded Aug 14, 2026
+3dSEC Form 4

Evidence

11
LG
Liu GeneChief Accounting Officer
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$80K
492 sh
Aug 14, 2026Aug 17, 2026
traded Aug 14, 2026
+3dSEC Form 4

Evidence

11
LY
Landman YoavDirector, CHIEF TECHNOLOGY OFFICER
FROGJFrog Ltd
Open-market sale · 10b5-1 plan
SELL$167K
1,800 sh
Aug 13, 2026Aug 17, 2026
traded Aug 13, 2026
+4dSEC Form 4

Evidence

11
LG
Liu GeneChief Accounting Officer
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$122K
737 sh
Aug 13, 2026Aug 17, 2026
traded Aug 13, 2026
+4dSEC Form 4

Evidence

11
YA
Yeh Kuanling AmyChief Technology Officer
MAXMediaAlpha, Inc.
Open-market sale · 10b5-1 plan
SELL$163K
12.0K sh
Aug 14, 2026Aug 17, 2026
traded Aug 14, 2026
+3dSEC Form 4

Evidence

11
LY
Landman YoavDirector, CHIEF TECHNOLOGY OFFICER
FROGJFrog Ltd
Open-market sale · 10b5-1 plan
SELL$238K
2,600 sh
Aug 13, 2026Aug 17, 2026
traded Aug 13, 2026
+4dSEC Form 4

Evidence

10
KD
Kerr DouglasChief Medical Officer
DYNDyne Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$41K
1,556 sh
Aug 13, 2026Aug 17, 2026
traded Aug 13, 2026
+4dSEC Form 4

Evidence

10
FJ
Friedl-Naderer JohannaChief Commercial Officer
DYNDyne Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$5,939
226 sh
Aug 13, 2026Aug 17, 2026
traded Aug 13, 2026
+4dSEC Form 4

Evidence

9
PK
Papenfuss Donnalee KathleenEVP-Strategy and Communication
FASTFASTENAL CO
Option exercise
M$19K
1,364 sh
Aug 13, 2026Aug 17, 2026
traded Aug 13, 2026
+4dSEC Form 4

Evidence

9
HS
Hudson SymeriaDirector
UFPTUFP TECHNOLOGIES INC
Option exercise
M—
493 sh
Aug 13, 2026Aug 17, 2026
traded Aug 13, 2026
+4dSEC Form 4

Evidence

9
MF
Miller Michael FrancisChief Technology Officer
QTRXQuanterix Corp
Option exercise
M—
834 sh
Aug 15, 2026Aug 17, 2026
traded Aug 15, 2026
+2dSEC Form 4

Evidence

9
WS
Watterson SarahDirector
RKTRocket Companies, Inc.
Grant or award
A—
14.6K sh
Aug 17, 2026Aug 17, 2026
traded Aug 17, 2026
+0dSEC Form 4

Evidence

9
MF
Miller Michael FrancisChief Technology Officer
QTRXQuanterix Corp
Option exercise
M—
372 sh
Aug 15, 2026Aug 17, 2026
traded Aug 15, 2026
+2dSEC Form 4

Evidence

9
RA
Renner AlexandraChief Product Officer
OKLOOklo Inc.
Option exercise
M—
1,201 sh
Aug 13, 2026Aug 17, 2026
traded Aug 13, 2026
+4dSEC Form 4

Evidence

9
MF
Miller Michael FrancisChief Technology Officer
QTRXQuanterix Corp
Option exercise
M—
135 sh
Aug 15, 2026Aug 17, 2026
traded Aug 15, 2026
+2dSEC Form 4

Evidence

9
KS
Kornowski SophieDirector
MAZEMaze Therapeutics, Inc.
Grant or award
A—
36.0K sh
Aug 13, 2026Aug 17, 2026
traded Aug 13, 2026
+4dSEC Form 4

Evidence

9
CE
Cieslik ElzbietaEVP & CAO of Bank
WBSWEBSTER FINANCIAL CORP
Tax withholding
F$41K
522 sh
Aug 13, 2026Aug 17, 2026
traded Aug 13, 2026
+4dSEC Form 4

Evidence

9
AY
Andorn Karni YarlDirector
CAMTCAMTEK LTD
Option exercise
M—
880 sh
Aug 13, 2026Aug 17, 2026
traded Aug 13, 2026
+4dSEC Form 4

Evidence

9
FJ
Fengler JustinSee Remarks
GDRXGoodRx Holdings, Inc.
Option exercise
M—
10.1K sh
Aug 15, 2026Aug 17, 2026
traded Aug 15, 2026
+2dSEC Form 4

Evidence

9
PK
Papenfuss Donnalee KathleenEVP-Strategy and Communication
FASTFASTENAL CO
Option exercise
M—
1,364 sh
Aug 13, 2026Aug 17, 2026
traded Aug 13, 2026
+4dSEC Form 4

Evidence

9
HJ
Hanson JohnChief of Staff
OKLOOklo Inc.
Option exercise
M—
961 sh
Aug 13, 2026Aug 17, 2026
traded Aug 13, 2026
+4dSEC Form 4

Evidence

9
GY
Grant-Huerta YaninaChief Financial Officer
IMAImageneBio, Inc.
Grant or award
A—
65.0K sh
Aug 14, 2026Aug 17, 2026
traded Aug 14, 2026
+3dSEC Form 4

Evidence

9
CC
Costello Keith ConanEVP & Chief Operating Officer
RMNIRimini Street, Inc.
Grant or award
A—
150.0K sh
Aug 17, 2026Aug 17, 2026
traded Aug 17, 2026
+0dSEC Form 4

Evidence

9
RS
Reeder Raymond SeanCorporate Controller & CAO
ROGROGERS CORP
Tax withholding
F$2,144
15 sh
Aug 14, 2026Aug 17, 2026
traded Aug 14, 2026
+3dSEC Form 4

Evidence

9
MF
Miller Michael FrancisChief Technology Officer
QTRXQuanterix Corp
Option exercise
M—
834 sh
Aug 15, 2026Aug 17, 2026
traded Aug 15, 2026
+2dSEC Form 4

Evidence

9
PK
Papenfuss Donnalee KathleenEVP-Strategy and Communication
FASTFASTENAL CO
Option exercise
M—
7,894 sh
Aug 13, 2026Aug 17, 2026
traded Aug 13, 2026
+4dSEC Form 4

Evidence

9
MF
Miller Michael FrancisChief Technology Officer
QTRXQuanterix Corp
Option exercise
M—
372 sh
Aug 15, 2026Aug 17, 2026
traded Aug 15, 2026
+2dSEC Form 4

Evidence

9
MM
Meeker MattDirector, Executive Chairman
BARKBark, Inc.
Tax withholding
F$7,297
721 sh
Aug 14, 2026Aug 17, 2026
traded Aug 14, 2026
+3dSEC Form 4

Evidence

9
GY
Grant-Huerta YaninaChief Financial Officer
IMAImageneBio, Inc.
Grant or award
A—
56.0K sh
Aug 14, 2026Aug 17, 2026
traded Aug 14, 2026
+3dSEC Form 4

Evidence

9
NJ
Nason JenniferDirector
ACNAccenture plc
Grant or award
A—
9 sh
Aug 14, 2026Aug 17, 2026
traded Aug 14, 2026
+3dSEC Form 4

Evidence

9
PY
Park Angie YChief Financial Officer
ACNAccenture plc
Grant or award
A—
23 sh
Aug 14, 2026Aug 17, 2026
traded Aug 14, 2026
+3dSEC Form 4

Evidence

9
HJ
Hanson JohnChief of Staff
OKLOOklo Inc.
Option exercise
M—
961 sh
Aug 13, 2026Aug 17, 2026
traded Aug 13, 2026
+4dSEC Form 4

Evidence

9
WR
Wheeler Benjamin RichardChief Financial Officer
MYGNMYRIAD GENETICS INC
Tax withholding
F$27K
8,761 sh
Aug 16, 2026Aug 17, 2026
traded Aug 16, 2026
+1dSEC Form 4

Evidence

9
PA
Patton James AnthonyDirector
NONENONEWILSON BANK HOLDING CO
Option exercise
M—
3,000 sh
Aug 17, 2026Aug 17, 2026
traded Aug 17, 2026
+0dSEC Form 4

Evidence

9
UM
Uotani MasahikoDirector
ACNAccenture plc
Grant or award
A—
9 sh
Aug 14, 2026Aug 17, 2026
traded Aug 14, 2026
+3dSEC Form 4

Evidence